Nextage Therapeutics Ltd (NXTG) - Cash Flow Conversion Efficiency

Latest as of June 2022: -0.730x

Based on the latest financial reports, Nextage Therapeutics Ltd (NXTG) has a cash flow conversion efficiency ratio of -0.730x as of June 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.72 Million ≈ $-4.61K USD) by net assets (ILA2.36 Million ≈ $6.32K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Nextage Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Nextage Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NXTG current and long-term liabilities for a breakdown of total debt and financial obligations.

Nextage Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nextage Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Witbe Net SA PA:ALWIT	0.366x
FIREFOX GOLD CORP. F:FIY	N/A
Teuza A Fairchild Technology Venture Ltd TA:TUZA	-0.017x
Hensel Davest Indonesia Tbk PT JK:HDIT	0.000x
Elecster Oyj A HE:ELEAV	0.052x
Till Capital Ltd V:TIL	-0.014x
North Atlantic Smaller Companies Investment Trust PLC LSE:NAS	0.005x
Sanwil Holding SA WAR:SNW	0.005x

Annual Cash Flow Conversion Efficiency for Nextage Therapeutics Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Nextage Therapeutics Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Nextage Therapeutics Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA-5.54 Million ≈ $-14.84K	ILA-795.00K ≈ $-2.13K	0.144x	-82.62%
2023-12-31	ILA-2.74 Million ≈ $-7.34K	ILA-2.26 Million ≈ $-6.06K	0.826x	-94.14%
2022-12-31	ILA-426.00K ≈ $-1.14K	ILA-6.01 Million ≈ $-16.12K	14.113x	+283.24%
2021-12-31	ILA516.00K ≈ $1.38K	ILA-3.97 Million ≈ $-10.65K	-7.702x	-76.95%
2020-12-31	ILA1.45 Million ≈ $3.89K	ILA-6.31 Million ≈ $-16.92K	-4.352x	-442.90%
2019-12-31	ILA3.66 Million ≈ $9.80K	ILA-2.93 Million ≈ $-7.86K	-0.802x	-126.70%
2018-12-31	ILA-1.65 Million ≈ $-4.42K	ILA-4.95 Million ≈ $-13.28K	3.003x	+334.96%
2017-12-31	ILA4.44 Million ≈ $11.90K	ILA-5.67 Million ≈ $-15.20K	-1.278x	--

About Nextage Therapeutics Ltd

TA:NXTG Israel Drug Manufacturers - Specialty & Generic

Market Cap

$5.79 Million

ILA2.16 Billion ILA

Market Cap Rank

#28070 Global

#411 in Israel

Share Price

ILA64.10

Change (1 day)

-17.72%

52-Week Range

ILA64.10 - ILA106.50

All Time High

ILA5080.00